may be required prior to administration of these drugs for some of our commercial, non-HMO members. We encourage you to review the available resources for each health plan on the Resources page. Prior Authorization required through AIM. This site will help you understand how the Carelon medical oncology program works, and the benefits for both providers and your patients. Our pathway regimens address the majority of cancer cases in adults, representing 95 percent of cancer medication spending. Use Availitys electronic authorization tool to quickly see if a pre-authorization is required for a medical service, submit your. But in recent years, some insurers have started requiring prior authorization even for low-cost generic drugs, said Andrew Spector, a neurologist who specializes in sleep medicine at Duke Health. It also promotes adherence to our cancer treatment pathways, regimens our panel of academic and community-based oncologists determined to have optimal efficacy and minimal toxicity. On the Authorization page, select the AIM (BCBSIL) link in the Additional Authorizations and Referrals section. The anti-seizure medication that worked for Doraiswamy’s patient is expensive. Our program addresses infused cancer treatment utilization, including chemotherapies, biological therapies, and supportive drugs. To further control cost and quality, we simultaneously review complete regimens, including supportive drugs, for alignment with pathways and medical policy. Our medical oncology program leverages our cancer treatment pathways, cancer regimens that optimally balance efficacy and toxicity, to support high-quality, high-value care for members. Carelon Medical Benefits Management’s (Carelon MBM) medical oncology program helps improve care provided to members with cancer.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |